SAD/MAD Study to Assess Safety, Tolerability, PK & PD of MEDI1814 in Subjects With Mild-Moderate Alzheimer's Disease.
Clinical trial NCT02036645 · COMPLETED
Trial details
- NCT number
- NCT02036645
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-04
- Primary completion
- 2016-09-15
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.